Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8693508rdf:typepubmed:Citationlld:pubmed
pubmed-article:8693508lifeskim:mentionsumls-concept:C0015959lld:lifeskim
pubmed-article:8693508lifeskim:mentionsumls-concept:C0016263lld:lifeskim
pubmed-article:8693508lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:8693508lifeskim:mentionsumls-concept:C0140430lld:lifeskim
pubmed-article:8693508lifeskim:mentionsumls-concept:C0522529lld:lifeskim
pubmed-article:8693508pubmed:issue5lld:pubmed
pubmed-article:8693508pubmed:dateCreated1996-8-29lld:pubmed
pubmed-article:8693508pubmed:abstractTextDetermination of the volume of fetal D-positive cells in the circulation of D-negative women after delivery is carried out to determine whether additional prophylactic anti-D should be given to the mother. Although the Kleihauer-Betke test is still widely used to calculate the fetomaternal hemorrhage, increasing use is being made of flow cytometry.lld:pubmed
pubmed-article:8693508pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8693508pubmed:languageenglld:pubmed
pubmed-article:8693508pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8693508pubmed:citationSubsetIMlld:pubmed
pubmed-article:8693508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8693508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8693508pubmed:statusMEDLINElld:pubmed
pubmed-article:8693508pubmed:monthMaylld:pubmed
pubmed-article:8693508pubmed:issn0041-1132lld:pubmed
pubmed-article:8693508pubmed:authorpubmed-author:TaylorEElld:pubmed
pubmed-article:8693508pubmed:authorpubmed-author:AustinEElld:pubmed
pubmed-article:8693508pubmed:authorpubmed-author:BromelowIIlld:pubmed
pubmed-article:8693508pubmed:authorpubmed-author:KumpelB MBMlld:pubmed
pubmed-article:8693508pubmed:authorpubmed-author:Lloyd-EvansPPlld:pubmed
pubmed-article:8693508pubmed:issnTypePrintlld:pubmed
pubmed-article:8693508pubmed:volume36lld:pubmed
pubmed-article:8693508pubmed:ownerNLMlld:pubmed
pubmed-article:8693508pubmed:authorsCompleteYlld:pubmed
pubmed-article:8693508pubmed:pagination432-7lld:pubmed
pubmed-article:8693508pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:meshHeadingpubmed-meshheading:8693508-...lld:pubmed
pubmed-article:8693508pubmed:year1996lld:pubmed
pubmed-article:8693508pubmed:articleTitleUse of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of fetomaternal hemorrhage by flow cytometry.lld:pubmed
pubmed-article:8693508pubmed:affiliationInternational Blood Group Reference Laboratory, Southmead Hospital, Bristol, UK.lld:pubmed
pubmed-article:8693508pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8693508pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8693508lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8693508lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8693508lld:pubmed